Publications


Association of arsenic exposure with PDGF-BB in vitro and in a South Texas population exposed through drinking water;
Svetlik, AE, Hasan, NT, Trisha, NF, White, DW, Satkunasivam, R, Johnson, NM & Roh, T 2025, , Toxicology and Applied Pharmacology, vol. 499, 117316. https://doi.org/10.1016/j.taap.2025.117316

A parametric study of motion and attachment to capillary walls of circulating tumor cells (CTCs) interacting with non-activated and activated platelets;
Simic, V, Nikolic, A, Ning, S, Milosevic, M, Leonard, F, Liu, X & Kojic, M 2025, , Computer Methods and Programs in Biomedicine, vol. 264, 108699. https://doi.org/10.1016/j.cmpb.2025.108699

The effect of the foreign body response on drug elution from subdermal delivery systems;
Capuani, S, Hernandez, N, Campa-Carranza, JN, Di Trani, N, Yoshikawa, T, Farina, M, Joubert, AL, Caffey, CA, Simeone, A, Cho, SW, Stayton, PS, Chua, CYX & Grattoni, A 2025, , Biomaterials, vol. 317, 123110, pp. 123110. https://doi.org/10.1016/j.biomaterials.2025.123110

Fertility-sparing treatment in early-stage cervical adenocarcinoma: assessing feasibility and limitations;
Lecuona, IV, Martínez, ZRM, Meschini, T, Okoye, E, Nodler, JL & Ramirez, PT 2025, , International Journal of Gynecological Cancer, vol. 35, no. 4, 101745. https://doi.org/10.1016/j.ijgc.2025.101745

Contrastive learning in brain imaging;
Xu, X & Wong, STC 2025, , Computerized Medical Imaging and Graphics, vol. 121, 102500. https://doi.org/10.1016/j.compmedimag.2025.102500

Outcomes for Early Liver Transplantation for Alcohol-associated Liver Disease in High-acuity Liver Transplant Recipients with Alcohol Use Disorder;
Meinders, AM, Connor, AA, Ontiveros, J, Elaileh, A, Patel, K, Todd, J, Nottage, DL, Brombosz, EW, Moore, LW, Simon, CJ, Cheah, YL, Hobeika, MJ, Mobley, CM, Saharia, A, Basra, T, Kodali, S, Victor, DW, Lee, BP, Terrault, N, Li, XC, Gaber, AO & Ghobrial, RM 2025, , Transplantation Direct, vol. 11, no. 4, e1776. https://doi.org/10.1097/TXD.0000000000001776

Transplantation for Peri-Hilar and Intrahepatic Cholangiocarcinoma With mTOR Immunosuppression;
Semaan, S, Connor, AA, Saharia, A, Kodali, S, Elaileh, A, Patel, K, Soliman, N, Basra, T, Victor, DW, Simon, CJ, Cheah, YL, Hobeika, MJ, Mobley, CM, Dhingra, S, Schwartz, MR, Maqsood, A, Heyne, K, Abdelrahim, M, Li, XC, Javle, M, Vauthey, JN, Gaber, AO & Ghobrial, RM 2025, , Transplantation Proceedings, vol. 57, no. 2, pp. 255-263. https://doi.org/10.1016/j.transproceed.2025.02.001

HER2-positive breast cancer in patients with BRCA1/2 pathogenic variants: Case series and literature review;
Munnangi, P, Niravath, PA, Chang, JC & Sun, K 2025, , Current Problems in Cancer: Case Reports, vol. 17, 100335. https://doi.org/10.1016/j.cpccr.2024.100335

Industry-Sponsored Research Funding to Urologists in the United States Between 2014 and 2022;
Murayama, A, Nguyen, DD, Nguyen, ALV, Murad, L, Cheng, A, Elterman, DS, Kulkarni, GS, Bhojani, N, Satkunasivam, R, Trinh, QD, Marshall, DC & Wallis, CJD 2025, , Urology Practice, vol. 12, no. 2, pp. 282-290. https://doi.org/10.1097/UPJ.0000000000000742

Utilization and Outcomes of the 21-Gene Recurrence Score in pN2 Breast Cancer Patients;
Haque, W, Verma, V, Mangalampalli, N, Schwartz, MR, Butler, EB, Sun, K, Jain, D, Arentz, C, Ramakrishnan, A & Teh, BS 2025, , Anticancer Research, vol. 45, no. 3, pp. 1055-1061. https://doi.org/10.21873/anticanres.17492